SEC Form 4 · accession 0001242215-26-000014
Milestone Pharmaceuticals Inc. · MIST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Papa
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001408443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.22 | Jun 10, 2026 | A | 77,000 | A | — | Jun 10, 2036 | Common Stock | 77,000 | 77,000 | D |
Explanation of responses
- F1This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.